The Company is an investment holding company. The company was incorporated in the Cayman Islands on January 31, 2022. The company s listing date expected to be on or about Wednesday, September 17, 2025 on the main board of Stock Exchange. Its subsidiaries are principally engaged in sales of pharmaceutical and healthcare products, as well as provision of digital healthcare and wellness solutions and related services in the PRC.
HISTORY
The following table summarizes the key business development milestones of Group:
2005 The Company was established Shenzhen Ningyuan, one of company s major subsidiaries and onshore holding company prior to the Reorganization.
The Company was registered the domain name of our Healthcare 160 website, www.91160.com.
2006 The Company was launched our Blue Dragonfly Hospital Infection Real-time Surveillance System (formerly known as Hospital Infection Surveillance
System and Blue Dragonfly Infectious Disease Real-time Monitoring System
2009 The Company was launched Jiuyitong platform.
2010 The Company was launched online appointment business and Healthcare 160 Platform.
2015 The Company was launched Hospital Full-Process System.
2016 The Company was launched pharmaceutical and healthcare products retail business.
2018 The Company was launched pharmaceutical and healthcare products wholesale business.
2020 The Company was started to expand initial success in Shenzhen to other major cities including Guangzhou, Shanghai and Beijing.
2021 The Company was obtained the Internet hospital license for Healthcare 160 Platform.
2022 The Company was launched 160 Cloud Hospital, an advanced online management platform.
2023 The Company was entered into a collaboration agreement with a leading global provider of information and communications technology infrastructure
and smart devices incorporated in China to officially list Healthcare 160 app on the service grid of all smart devices developed by it.
总部
9/F, 11/F - 12/F, Building 2, Yongxin Times Square, 4078 Dongbin Road, Nanshan Street
深圳; 广东;
联系方式: 购买健康160国际有限公司 (160 Health International Ltd.)报告以查看信息。
EMIS公司简介是一个更大的信息服务的一部分,它结合了公司,行业和国家数据和分析在超过125个新兴市场.
请求EMIS服务的演示查看更多信息, 申请试用